[go: up one dir, main page]

GB0104749D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB0104749D0
GB0104749D0 GBGB0104749.7A GB0104749A GB0104749D0 GB 0104749 D0 GB0104749 D0 GB 0104749D0 GB 0104749 A GB0104749 A GB 0104749A GB 0104749 D0 GB0104749 D0 GB 0104749D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0104749.7A
Other versions
GB2372444A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0104749A priority Critical patent/GB2372444A/en
Publication of GB0104749D0 publication Critical patent/GB0104749D0/en
Priority to NZ527532A priority patent/NZ527532A/en
Priority to SK1072-2003A priority patent/SK10722003A3/en
Priority to KR10-2003-7011178A priority patent/KR20030077042A/en
Priority to RU2003128971/15A priority patent/RU2003128971A/en
Priority to DE60206889T priority patent/DE60206889T2/en
Priority to CA002439366A priority patent/CA2439366A1/en
Priority to PL02365746A priority patent/PL365746A1/en
Priority to EP02712105A priority patent/EP1368001B1/en
Priority to PCT/GB2002/000766 priority patent/WO2002067893A2/en
Priority to MXPA03007641A priority patent/MXPA03007641A/en
Priority to JP2002567261A priority patent/JP3548566B2/en
Priority to AT02712105T priority patent/ATE307571T1/en
Priority to EEP200300416A priority patent/EE200300416A/en
Priority to IL15738902A priority patent/IL157389A0/en
Priority to CZ20032225A priority patent/CZ20032225A3/en
Priority to HU0302847A priority patent/HUP0302847A3/en
Priority to CNA028087356A priority patent/CN1503662A/en
Priority to US10/468,276 priority patent/US20040067257A1/en
Priority to UY27186A priority patent/UY27186A1/en
Priority to ARP020100712A priority patent/AR032912A1/en
Publication of GB2372444A publication Critical patent/GB2372444A/en
Priority to IS6915A priority patent/IS6915A/en
Priority to ZA200306383A priority patent/ZA200306383B/en
Priority to NO20033785A priority patent/NO20033785L/en
Priority to JP2004041583A priority patent/JP2004143185A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0104749A 2001-02-27 2001-02-27 A pharmaceutical formulation comprising bicalutamide and a hydroxypropylmethylcellulose polymer Withdrawn GB2372444A (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB0104749A GB2372444A (en) 2001-02-27 2001-02-27 A pharmaceutical formulation comprising bicalutamide and a hydroxypropylmethylcellulose polymer
US10/468,276 US20040067257A1 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation
AT02712105T ATE307571T1 (en) 2001-02-27 2002-02-22 PHARMACEUTICAL FORMULATION CONTAINING BICALUTAMID
IL15738902A IL157389A0 (en) 2001-02-27 2002-02-22 A pharmaceutical formulation comprising bicalutamide and an enteric polymer and use thereof as a medicament
KR10-2003-7011178A KR20030077042A (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide
RU2003128971/15A RU2003128971A (en) 2001-02-27 2002-02-22 PHARMACEUTICAL PRODUCT
DE60206889T DE60206889T2 (en) 2001-02-27 2002-02-22 PHARMACEUTICAL FORMULATION CONTAINING BICALUTAMIDE
CA002439366A CA2439366A1 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide
PL02365746A PL365746A1 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide
EP02712105A EP1368001B1 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide
PCT/GB2002/000766 WO2002067893A2 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide
MXPA03007641A MXPA03007641A (en) 2001-02-27 2002-02-22 Pharmaceutical formulation.
JP2002567261A JP3548566B2 (en) 2001-02-27 2002-02-22 Pharmaceutical preparations
NZ527532A NZ527532A (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide
EEP200300416A EE200300416A (en) 2001-02-27 2002-02-22 Pharmaceutical form
SK1072-2003A SK10722003A3 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide in solid dispersion with an enteric polymer and use thereof
CZ20032225A CZ20032225A3 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation
HU0302847A HUP0302847A3 (en) 2001-02-27 2002-02-22 Pharmaceutical formulation comprising bicalutamide
CNA028087356A CN1503662A (en) 2001-02-27 2002-02-22 pharmaceutical preparations
UY27186A UY27186A1 (en) 2001-02-27 2002-02-26 PHARMACEUTICAL FORMULATION
ARP020100712A AR032912A1 (en) 2001-02-27 2002-02-27 PHARMACEUTICAL FORMULATION
IS6915A IS6915A (en) 2001-02-27 2003-08-15 composition
ZA200306383A ZA200306383B (en) 2001-02-27 2003-08-15 Pharmaceutical formulation comprising bicalutamide.
NO20033785A NO20033785L (en) 2001-02-27 2003-08-26 Pharmaceutical formulation
JP2004041583A JP2004143185A (en) 2001-02-27 2004-02-18 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0104749A GB2372444A (en) 2001-02-27 2001-02-27 A pharmaceutical formulation comprising bicalutamide and a hydroxypropylmethylcellulose polymer

Publications (2)

Publication Number Publication Date
GB0104749D0 true GB0104749D0 (en) 2001-04-18
GB2372444A GB2372444A (en) 2002-08-28

Family

ID=9909542

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0104749A Withdrawn GB2372444A (en) 2001-02-27 2001-02-27 A pharmaceutical formulation comprising bicalutamide and a hydroxypropylmethylcellulose polymer

Country Status (2)

Country Link
GB (1) GB2372444A (en)
ZA (1) ZA200306383B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06008520A (en) * 2004-01-28 2008-02-13 Androscience Corp Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof.
DE202006000585U1 (en) * 2006-01-13 2007-05-24 Wanzl Metallwarenfabrik Gmbh Dividing means

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
AU5925399A (en) * 1998-09-16 2000-04-03 Oncopharmaceutical, Inc. Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent

Also Published As

Publication number Publication date
GB2372444A (en) 2002-08-28
ZA200306383B (en) 2004-11-15

Similar Documents

Publication Publication Date Title
GB0102342D0 (en) Pharmaceutical formulation
GB0118689D0 (en) Pharmaceutical formulation
GB0319041D0 (en) Pharmaceutical Formulations
MXPA03007641A (en) Pharmaceutical formulation.
PL366432A1 (en) Pharmaceutical formulation
AU2002257582A1 (en) Pharmaceutical formulation
GB0121715D0 (en) Pharmaceutical formulations
GB2380129B (en) Pharmaceutical formulations
GB0120701D0 (en) Pharmaceutical formulations
GB0103638D0 (en) Pharmaceutical formulations
IL161306A0 (en) Pharmaceutical formulation comprising (r)-bicalutamide
GB0105560D0 (en) Pharmaceutical formulations
GB0014851D0 (en) Novel pharmaceutical formulation
GB0124455D0 (en) Pharmaceutical formulations
GB0104749D0 (en) Pharmaceutical formulation
GB0014892D0 (en) Novel pharmaceutical formulation
GB0014883D0 (en) Novel pharmaceutical formulation
GB0014947D0 (en) Novel pharmaceutical formulation
GB0014869D0 (en) Novel pharmaceutical formulation
GB0128138D0 (en) Pharmaceutical use
GB0124712D0 (en) Pharmaceutical formulation
ZA200402731B (en) Pharmaceutical formulation.
EP1414417A4 (en) Pharmaceutical formulation
AU2003238900A8 (en) Pharmaceutical formulation
GB0101966D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)